Delivery Order SPE2DB22D3011-SPE2DB25FP8YV
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$52K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,452.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,893.22 firm fixed price delivery order is for ENGERIX-B 20 MCG/ML SYRNML, a type of vaccine product. The contract has a period of performance extending to June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.20 delivery order contract is for ENGERIX-B 20 MCG/ML VIALML, a hepatitis B vaccine. The contract is a Firm Fixed Price arrangement with a period of performance ending on March 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA). The $9,129.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,124.30, is for the delivery of ENGERIX-B 10MCG 10S, a vaccine product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,811.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order against the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,704.88 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a performance period through February 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,359.88, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 17, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMPPY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,250.12 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,396.90 fixed-price delivery order is for the supply of the ENGERIX-B 20 MCG/ML SYRNML vaccine product. The contract has a period of performance extending through May 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...